N	Concordance
1	s of the 5'-flanking region using MCF-7 breast cancer cells indicated that the s
2	ll have true antiestrogens for adjuvant breast cancer therapy. Tamoxifen is not 
3	with breast implants have more advanced breast cancer at diagnosis or a worse pr
4	her patients with early-stage bilateral breast cancer can be treated with defini
5	of which sometimes  follow conservative breast cancer surgery, are partially ind
6	and date of last contact. Contralateral breast cancer was considered to be a sec
7	 of regional nodal irradiation in early breast cancer remains controversial. Fai
8	count for approximately 45% of familial breast cancer and 90% of inherited breas
9	   Because many of the risk factors for breast cancer are related to natural  ho
10	 who belong to families with hereditary breast cancer and who test  positive for
11	  radiotherapy in women with stage I/II breast cancer treated with tylectomy who
12	 patients with newly diagnosed invasive breast cancer and therefore a defined ra
13	east cancer.  The  impression that male breast cancer has a worse prognosis may 
14	pens, the disease is called  metastatic breast cancer and the new tumor is calle
15	 disease-free survival in node-negative breast cancer patients. Because conflict
16	 express RAR alpha, whereas ER-negative breast cancer cell lines are refractory 
17	ntroduce new ways to reduce the risk of breast cancer in a small subset of women
18	 nd had not experienced a recurrence of breast cancer were asked to consider ran
19	rapy in  patients with primary operable breast cancer who had estrogen receptor-
20	and the RR of developing postmenopausal breast cancer is reported in only half o
21	local response of superficial recurrent breast cancer to radiation therapy were